Lung cancer: screening, diagnosis, and investigation - clinical fact sheet and MCQ
Overview
Lung cancer remains the leading cause of cancer-related mortality in Australia. Early detection significantly improves outcomes. Despite advancements in therapy, prognosis is strongly linked to stage at diagnosis—5-year survival is 68% for stage 1 disease, but just 3% at stage 4. However, symptoms are often non-specific, which can delay recognition and referral. Primary care clinicians are critical in initiating timely investigation and referral, especially given that many patients have multiple GP consultations prior to diagnosis.
Up to 10% of males and 35% of females diagnosed with lung cancer have never smoked, so it is vital to consider the diagnosis of lung cancer in non -smokers..
In July 2025, the new National lung cancer screening program commences, including new Medicare items and reporting requirements.
Lung cancer screening in primary practice
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas eu odio in nibh placerat tempor ac vel mauris. Nunc efficitur sapien at nisl semper dapibus. Nullam tempor eros sed dui aliquam lacinia. Nunc feugiat facilisis ex.
Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Maecenas mauris nibh, tempus sit amet erat vel, pellentesque maximus ipsum. Suspendisse dui nunc, porta ac ultricies id, sodales eu ante.
The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreMedcast Medical Education Team
The incidence of eosinophilic oesophagitis (EoE) is increasing among Australians. This fact sheet covers the risk factors and associations, diagnosis, and management strategies for EoE, equipping GPs to monitor symptoms and support treatment adherence. 30mins each of RP and EA CPD available with the quiz.
Medcast Medical Education Team
MBS item number 695 came into effect on 1st July 2025. This new item number remunerates GPs for comprehensive assessment and management of menopause-related symptoms. Learn what you need to know about MBS item 695 with this fact sheet, including eligibility criteria and practice tips. 30mins each of RP and EA CPD with the quiz.
PRECISE Education Team
An increasing number of pregnant patients are seeking advice from their GP about prenatal genetic testing. This FastTrack covers non-invasive prenatal testing/screening, including how it works, indications, limitations, and different types of testing panels. 30mins each of RP and EA CPD available.